MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

Recruiting now · Not applicable

Conditions studied: Prostate Cancer, Prostate Adenocarcinoma, Prostate Neoplasm

In brief

Doctors leading this study hope to learn about a software that researchers at the University of Chicago have developed to help analyze radiographic images (different techniques for taking images that allow doctors to visualize the body's internal structures) of the prostate. Participation in this research will last about 12 months. There is a one-time MRI and 1-2 biopsies and then the investigator would like to follow the participant's progress.

Key facts

Study ID

NCT05710380

Run by

University of Chicago

People needed

180

Starts

2023-04-26

Expected to finish

2026-05-01

Last updated by the study team

2026-04-27

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patients with known or suspected prostate cancer who have been referred for a diagnostic magnetic resonance imaging (MRI) exam of the prostate, to be followed by an MRI-guided fusion biopsy of the prostate.
• Voluntary written informed consent before the MRI examination.

You may not qualify if…

• Subjects incapable of giving informed written consent.
• Subjects who cannot adhere to the experimental protocols for any reason, or have an inability to communicate with the researcher;
• Subjects with psychiatric disorders that affect their ability to consent for themselves will be excluded and not the entire population of patients with psychiatric disorders.
• Prisoners.
• Minor children (under the age of 18 years old).
• Patients with previous treatments (surgery, radiation, focal ablation, hormone or other chemotherapy) for prostate cancer.

Where it is running

• University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.